VagiVital Intimate Calming Gel provides immediate soothing and moisturizing effects for vulvodynia and relieves symptoms such as dryness, irritation, and itching. The product is based on the company's clinically proven gel formulation and is intended for use on the external genital area.
Vulvodynia is a condition characterized by pain around the vaginal opening. The burden of the condition in a woman's life can be devastating, affecting sexual relationships daily activities, overall well-being, and quality of life. The prevalence of vestibulitis varies between studies but indicates that it affects one to two out of ten women aged 18 to 29. VagiVital Intimate Calming Gel is a valuable addition to Peptonic's existing portfolio of clinically proven self-care products for intimate medical conditions.
For further information, please contact:
Anna Linton, CEO
Email: anna.linton@peptonicmedical.se
Phone: +46 70-244 92 07
About Peptonic
The company's vision is to revolutionize intimate health by empowering women to diagnose, treat, and prevent intimate medical conditions independently and effectively. Intimate health shall be natural, safe, and easy for women to manage on their own.
Central to Peptonic's growth strategy is the geographical expansion of VagiVital and Vernivia through local partners. Peptonic Medical also intends to continuously broaden its product portfolio through acquisitions and the development of innovative and competitive products in-house. The company's mousse-based drug delivery technology, Venerol, and the gel base in VagiVital create favorable conditions for expanding the portfolio.
The company is headquartered in Stockholm, Sweden, and has subsidiaries
https://news.cision.com/peptonic-medical-ab/r/peptonic-medical-ab-granted-patent-in-europe-for-relief-of-provoked-vulvodynia-in-women--product-rea,c3992627
(c) 2024 Cision. All rights reserved., source